28th EORTC-NCI-AACR Symposium 2016

Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2016 Symposium brought together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology.

As a one-of-a-kind Symposium at the forefront of drug development, it enabled participants to apply the latest findings and knowledge in their work and practice. This edition also built on the success of the previous symposium which was widely praised for the quality of its programme, inspirational contributions and exclusive insights.